Page last updated: 2024-11-04

terfenadine and Alloxan Diabetes

terfenadine has been researched along with Alloxan Diabetes in 1 studies

Terfenadine: A selective histamine H1-receptor antagonist devoid of central nervous system depressant activity. The drug was used for ALLERGY but withdrawn due to causing LONG QT SYNDROME.

Research Excerpts

ExcerptRelevanceReference
"Pregabalin was a very efficacious antiallodynic and analgesic drug capable of increasing the pain thresholds for tactile allodynia and thermal hyperalgesia in diabetic mice."3.79Evaluation of analgesic, antioxidant, cytotoxic and metabolic effects of pregabalin for the use in neuropathic pain. ( Gluch-Lutwin, M; Librowski, T; Nawiesniak, B; Sałat, K, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sałat, K1
Librowski, T1
Nawiesniak, B1
Gluch-Lutwin, M1

Other Studies

1 other study available for terfenadine and Alloxan Diabetes

ArticleYear
Evaluation of analgesic, antioxidant, cytotoxic and metabolic effects of pregabalin for the use in neuropathic pain.
    Neurological research, 2013, Volume: 35, Issue:9

    Topics: 3T3-L1 Cells; Analgesics; Animals; Antioxidants; Cell Death; Diabetes Mellitus, Experimental; Diabet

2013